Cough medicine could be used in new treatment for Parkinson’s disease
A large-scale Phase 3 clinical trial to establish ambroxol’s potential to slow the progression of Parkinson’s disease, will start in early 2023….[read more]
Updated hourly
A large-scale Phase 3 clinical trial to establish ambroxol’s potential to slow the progression of Parkinson’s disease, will start in early 2023….[read more]